Cytogenetic evolution of human ovarian cell lines associated with chemoresistance and loss of tumorigenicity

Analytical Cellular Pathology

Volumn 25, Issue 3, 2003, Pages 115-122

  Struski, Stéphanie ^a   Doco Fenzy, Martine ^b   Koehler, Michael ^c   Chudoba, Ilse ^d   Levy, Francis ^e   Masson, Linda ^b   Michel, Nicole ^b   Ulrich, Evelyne ^b   Gruson, Nadine ^b   Bénard, Jean ^f   Potron, Gérard ^a   Cornillet Lefebvre, Pascale ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b HÔPITAL MAISON BLANCHE   (France)

^c ASI GmbH   (Germany)

^d MetaSystems   (Germany)

^e POLYTEC   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VINCRISTINE;

ARTICLE; CARCINOGENICITY; CELL LINE; CELL SUBPOPULATION; CHROMOSOME 11P; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 8; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DRUG RESISTANCE; EVOLUTION; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMICS; HUMAN; HUMAN CELL; KARYOTYPING; LOSS OF TUMORIGENICITY; MULTIDRUG RESISTANCE; OVARY CELL CULTURE; PHENOTYPE; PRIORITY JOURNAL; REVERTANT;

EID: 12444314596     PISSN: 09218912     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/151042     Document Type: Article

References (30)

1. L.G. Baggetto, Non-P-glycoprotein novel proteins involved in human cancer multidrug resistance, Bull. Cancer 84 (1997), 385-390.
2. J. Bénard, J. Da Silva, J.R. Teyssier and G. Riou, Overexpression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line, Int. J. Cancer 43 (1989), 471-477.
3. J. Bénard, J. Da Silva, M.C. De Blois, P. Boyer, P. Duvillard, E. Chiric and G. Riou, Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice, Cancer Res. 45 (1985), 4970-4979.
4. W.B. Coleman, S.L. Ricketts, K.M. Borchert, S.C. Presnell, G.L. Esch, K.D. McCullough, B.E. Weissman, G.J. Smith and J.W. Grisham, Induction of rat WT1 gene expression correlates with human chromosome 11p11.2-p12-mediated suppression of tumorigenicity in rat liver epithelial tumor cell lines, Int. J. Oncol. 14 (1999), 957-963.
5. M.K. Dodson, L.C. Hartmann, W.A. Cliby, K.A. DeLacey, G.L. Keeney, S.R. Ritland, J.Q. Su, K.C. Podratz and R.B. Jenkins, Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas, Cancer Res. 53 (1993), 4456-4460.
6. B. Dutrillaux and J. Lejeune, A new technic of analysis of the human karyotype? CR Acad. Sci. Hebd. Seances Acad. Sci. D 272 (1971), 2638-2640.
7. G.M. Hampton, L.A. Penny, R.N. Baergen, A. Larson, C. Brewer, S. Liao, R.M. Busby-Earle, A.W. Williams, C.M. Steel, C.C. Bird, E.J. Stanbridge and G.A. Evans, Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24, Proc. Natl. Acad. Sci. USA 91 (1994), 6953-6957.
8. A.B. Hill, J.M. Trent, F.H. Thompson, M.K. Danks and W.T. Beck, Loss of tumorigenicity in a methotrexate-resistant human leukemia cell line, Cancer Genet. Cytogenet. 70 (1993), 48-55.
9. M. Hirai, S. Yoshida, H. Kashiwagi, T. Kawamura, T. Ishikawa, M. Kaneko, H. Ohkawa, A. Nakagawara, M. Miwa and K. Uchida, 1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment, Genes Chromosomes Cancer 25 (1999), 261-269.
10. I. Horikawa, A. Okamoto, J. Yokota and M. Oshimura, Genetic heterogeneity of chromosome 11 associated with tumorigenicity in HeLa D98-OR cells, Cancer Genet. Cytogenet. 85 (1995), 97-100.
11. O.P. Kallioniemi, A. Kallioniemi, J. Piper, J. Isola, F.M. Waldman, J.W. Gray and D. Pinkel, Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors, Genes Chromosomes Cancer 10 (1994), 231-243.
12. A. Kallioniemi, O.P. Kallioniemi, D. Sudar, D. Rutovitz, J.W. Gray, F. Waldman and D. Pinkel, Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors, Science 258 (1992), 818-821.
13. M. Kirchhoff, T. Gerdes, J. Maahr, H. Rose, M. Bentz and H. Döohner, Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals, Genes Chromosomes Cancer 25 (1999), 410-413.
14. M. Kirchhoff, T. Gerdes, H. Rose, J. Maahr, A.M. Ottesen and C. Lundsteen, Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals, Cytometry 31 (1998), 163-173.
15. T. Knutsen, L.A. Mickley, T. Ried, E.D. Green, S. du Manoir, E. Schrock, M. Macville, Y. Ning, R. Robey, M. Polymeropoulos, R. Torres and T. Fojo, Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drag refractory ALL, Genes Chromosomes Cancer 23 (1998), 44-54.
16. K. Kudoh, M. Takano, T. Koshikawa, M. Hirai, Ś. Yoshida, Y. Mano, K. Yamamoto, K. Ishii, T. Kita, Y. Kikuchi, I. Nagata, M. Miwa and K. Uchida, Gains of 1q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients, Clin. Cancer Res. 5 (1999), 2526-2531.
17. K. Lee, M.G. Belinsky, D.W. Bell, J.R. Testa and G.D. Kruh, Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter, Cancer Res. 58 (1998), 2741-2747.
18. B. Leyland-Jones, L.R. Kelland, K.R. Harrap and L.R. Hiorns, Genomic imbalances associated with acquired resistance to platinum analogues, Am. J. Pathol. 155 (1999), 77-84.
19. P. Lichter, M. Bentz, S. Du Manoir and S. Joos, Comparative genomic hybridization, in: Human Chromosomes, Principles and Techniques, R.S. Verma and A. Babu, eds, McGraw-Hill, New York, 1995, pp. 191-210.
20. F. Mitelman, ISCN: An International System for Human Cytogenetic Nomenclature, S. Karger, Basel, 1995.
21. D. Nielsen and T. Skovsgaard, P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines, Biochim. Biophys. Acta 1139 (1992), 169-183.
22. P.H. Rao, J. Houldsworth, K. Dyomina, N.Z. Parsa, J.C. Cigudosa, D.C. Louie, L. Popplewell, K. Offit, S.C. Jhanwar and R.S. Chaganti, Chromosomal and gene amplification in diffuse large B-cell lymphoma, Blood 92 (1998), 234-240.
23. P.H. Rooney, D.A. Stevenson, S. Marsh, P.G. Johnston, N.E. Haites, J. Cassidy and H.L. McLeod, Comparative genomic hybridization analysis of chromosomal alterations induced by the development of resistance to thymidylate synthase inhibitors, Cancer Res. 58 (1998), 5042-5045.
24. S. Sabbioni, G. Barbanti-Brodano, C.M. Croce and M. Negrini, GOK: a gene at 11p15 involved in rhabdomyosarcoma and rhabdoid tumor development, Cancer Res. 57 (1997), 4493-4497.
25. P.V. Schoenlein, Molecular cytogenetics of multiple drug resistance, Cytotechnology 12 (1993), 63-89.
26. S. Struski, P. Cornillet-Lefebvre, M. Doco-Fenzy, J. Dufer, E. Ulrich, L. Masson, N. Michel, N. Gruson and G. Potron, Cytogenetic characterization of chromosomal rearrangement in a human vinblastine-resistant CEM cell line: use of comparative genomic hybridization and fluorescence in situ hybridization, Cancer Genet. Cytogenet. 132 (2002), 51-54.
27. S. Struski, M. Doco-Fenzy, A. Trussardi, L. Masson, N. Gruson, E. Ulrich, M. Proult, J.C. Jardillier, G. Potron and P. Cornillet-Lefebvre, Identification of chromosomal loci associated with non-P-glycoprotein-mediated multidrug resistance to topoisomerase II inhibitor in lung adenocarcinoma cell line by comparative genomic hybridization, Genes Chromosomes Cancer 30 (2001), 136-142.
28. J.R. Teyssier, J. Bénard, D. Ferre, J. Da Silva and L. Renaud, Drug-related chromosomal changes in chemoresistant human ovarian carcinoma cells, Cancer Genet. Cytogenet. 39 (1989), 35-43.
29. J.R. Teyssier, P. Couillin, J. Bénard, N. Ravisse, E. Ulrich and P. Cornillet, A multidrug-resistant ovarian carcinoma cell line with a malignant suppressed phenotype is a CD44 gene expression defective mutant, Cancer Genet. Cytogenet. 60 (1992), 14-19.
30. V.M. Wasenius, A. Jekunen, O. Monni, H. Joensuu, S. Aebi, S.B. Howell and S. Knuutila, Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells, Genes Chromosomes Cancer 18 (1997), 286-291.